AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $150,720 | +22.9% | 16,034 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $122,660 | +23.8% | 16,034 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $99,090 | -49.2% | 16,034 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $195,134 | +5.4% | 16,034 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $185,193 | +15.6% | 16,034 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $160,180 | -22.4% | 16,034 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $206,518 | -15.2% | 16,034 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $243,556 | -24.1% | 16,034 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $320,680 | +2.5% | 16,034 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $313,000 | -3.1% | 16,034 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $323,000 | +52.4% | 16,034 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $212,000 | – | 16,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |